Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
To me the virtual meetings of the last two years were of almost no value. Being in the room, talking to people, seeing the interactions, and being able to actually ask questions is pretty much completely lost in a virtual meeting. And in the two virtual meetings they were unable to limit the meeting to shareholders, which is supposed to be the point of a shareholder meeting, I think.
I believe that I mentioned a couple of years ago, when physical meetings were still the norm, that having a dial-in number of some sort would be nice for people unable to attend so at least they could hear what is going on. So a hybrid would be alright by me.
I will be at the ASM, unless they manage to hold it when I am not around. I expect it to be in-person. There is no real reason to hold it virtually at this point given the direction of CDC recommendations.
They are unlikely to answer the questions people really want to know about because that is not the point of the ASM. It is not where you announce big news. If they want to answer those questions, they will PR them.
If they plan to request an authorization for more shares, I think they need to have a published article and have released TLD beforehand.
I doubt that they will present at ASCO if it occurs before the Journal article is published. I also think that pinning one's hopes on ASCO or the ASM is a mistake, but we've been through that before.
Really? Lawyers are just people with some added education and ethics rules that are administered by other lawyers.
There is an inherent conflict of financial interest in many representations because the lawyer gets paid by the hour, so it is in their financial interest to bill as many hours as possible and therefore for the case, plea negotiations, or discovery to go on for as long as possible. In a contingency case, the lawyer gets a percentage of the recovery so even if the client is more interested in non-monetary concessions, the lawyer's pay is based solely on the cash settlement.
None of this is to suggest that I believe or disbelieve that there is a conflict of interest. I simply wouldn't ignore the possibility based solely on them being lawyers.
I have no idea what you are even saying. You can't have a delay in publishing TLD prior to the predicate event: datalock. In the datalock announcement they clearly state journal publication. Just because you didn't believe at the time that journal publication was coming before release of TPD doesn't mean that it wasn't talked about.
Sure, keep thinking that.
Once again. NWBO has NO control over when the article is published and therefore when TLD is announced. Not only don't they have any control over it, they quite possibly have no idea when it is going to be. So how can they guarantee anything? They provided a date by which Sawston was SUPPOSED to be certified based on what MHRA said is their timeframe and where did that get anyone?
And what is magical about the ASM? Why not by Tax Day? ASCO? Arbor Day? It is all just picking a random date out of the hat based on exactly zero and deciding that is the deadline.
A fair compromise? Between what and what? That suggests that what NWBO really wants is to just hang out bleeding money indefinitely and never bringing to market the cure for cancer they have invested the last decade plus of their lives to and which is going to make them all fantastically wealthy. The thing is, this is exactly the type of thing people were saying a year ago and what would we have gotten if they said something at the ASM last year? A completely random date they couldn't meet through no fault of their own.
Sorry but this all sounds like you are double-daring them or something. No backsies! If you want guarantees, buy bonds.
10baggerz:
I disagree. Not a big roasted pig and poi fan.
Also, suggesting they are 'dragging' this thing out at the very least implies that they are intentionally delaying release of a journal article, the timing of which they have pretty much no control over. And seriously, what conceivable explanation can they give right now if they were to release TLD without the article because people here are getting antsy?
Proposed PR: "We were going to wait for a journal to publish peer-reviewed results and explain the rather complex picture that has emerged as a result of changing endpoints and definitions of GBM. We went through the whole peer-review process, but some people on iHub threatened to sell as many as 50,000 shares! So we are just going to publish TLD and skip the article, which would have required us to allow them to publish first, so here is a page about how great we think things went. Please don't be mean and tear this apart because there is no independent analysis of it."
Also, as previously mentioned many times by me, please don't create more artificial deadlines based on nothing but your hopes and dreams for when TLD/article will be released. Just as the company has little control over release of the article, they are required to hold the ASM with 13 months of the prior ASM (https://codes.findlaw.com/ri/title-7-corporations-associations-and-partnerships/ri-gen-laws-sect-7-1-2-701.html) so they are not completely at liberty to select the timing of the ASM either. And they are not going to announce TLD at the ASM. That is not where news is released. (The Security and Exchange Commission's (SEC) enactment of Regulation FD on Aug. 15, 2000, effectively banned companies from selectively releasing material nonpublic information.)
. . . so, you admit that in fact people (including myself) were talking about requiring a publication back ~16 months ago.
Gotcha. Glad we are on the same page.
I disagree. First, the company stated in the datalock PR that they intended to publish the data in a "scientific publication." So someone absolutely spoke about it then.
They couldn't very well release TLD prior to datalock, so it is a bit of a stretch to say there was a delay in releasing TLD when they were still blinded.
Second, you make it sound like no one on this board talked about publication until recently, like in the last year or so, but I talked about it within 6 weeks of the datalock PR.
I certainly don't disagree but I find it a rather odd place to start leaking that sort of claim. Not that the Cambridge Whatever isn't a globally-recognized source of medical information.
That isn't how intellectual property works.
'Liau Protocol' is not registered as a trademark in the US and generally you can't register a trademark in the US that is primarily a surname.
Trademarks are meant to identify the source of goods or services. So in order to register a trademark, you need to designate one or more classes of goods. So 'Apple' for instance is registered to different people for different classes of goods, like computers and banking. So you can't just trademark and phrase because you came up with it.
Also, the ™ symbol designates something for which you have applied for a trademark, while ® designates something that is actually registered. And ? is used for Service Marks.
Likewise, you can't copyright phrases, in case that was the next plan.
I find it hard to accept that this message board:
It sounds like he is referring to NWBO's board but it is difficult to tell.
You are so far out of your league it is frankly embarrassing. Stick to making up warrant numbers.
Buying any OTC stock is a pretty serious risk. The market is far less regulated and there are far less protections for investors and far more scams or companies that just aren't going to survive. If you don't know what you are doing, you should expect to lose money, lots of it. And startup biotechs are far worse. An extremely small number of them survive. You don't need to be the investor king to know this. Just ask anyone who actually knows anything about investing.
The average investor should, under no circumstances, be buying sub $1 OTC Biotech startups.
If you are not willing to do a lot of due diligence, you are throwing your money away buying a bunch of stocks like this. If you don't understand the significance of today's PR, you should look at other investments.
There is no market. There are a bunch of longs holding shares, including company execs and some large investors friendly to them. Of the ~900MM shares out there, probably no more than 50MM (and that is a serious stretch) have been sold since October 2020, and most of those were warrants cashed to cover taxes because the warrants were expiring.
I tries to buy 500K in late December and over the course of a couple of hours I raised the price from $0.60 to $0.70, always staying above the supposed ask/bid and at the end was only able to grab a total of 100K shares. Buying 100K shares can raise the price of this stock more than 15% No one is selling except the occasional 'average investor' who was expecting imminent news.
Until we are on a major exchange and we have unimpeachable results, the share price is capped.
To everyone claiming that if NWBO were more open and forthcoming with news, or had released TLD back in October 2020, that their share price would be far higher, I present today's BB entries.
Do you actually need any more evidence of the futility of NWBO trying to respond to all of the ridiculous accusations than looking at what has come out today? Can there be any doubt that people will attack anything the company releases with the most desperate and absurd arguments? NWBO announces that Sawston is now producing DC-Vax for compassionate-use and immediately the posts come out picking the PR apart, making truly ludicrous claims and trying to turn good news into bad.
I challenge anyone on this board to write up a 1-page TLD memo to be distributed that can stand on its own for a couple of years pending approval of DC-Vax. Anyone who honestly thinks that releasing TLD without independent support need look no farther than the last 100 or so posts here.
He did not listen to my sage advice. Understandable, most of my advice probably isn't worth much but once-in-a-while I actually know what I am talking about. Plus, it is not like anyone on here really knows who I am or what qualification I have for giving advice.
Investing in general, and especially with a startup BioTech, is all about patience. Sure, you can make money jumping in and out, timing the market, using cost averaging, etc. etc. But the simple fact is that the Market is not a fair playing field and is not driven by perfect information and people do not always act logically or even in their own best interests.
Timing purchases and sales requires being right twice. So even if you have a history of 67% accuracy, that only gives you a 45% chance of hitting both buy and sell. Unpredictable events, from COVID to tensions around Ukraine, to crackdowns in Hong Kong can badly skew your odds and eventually they will catch up with you.
It is all about patience. Setting artificial deadlines is just about the very best way to destroy your objective enthusiasm for a stock. Building up in your mind that they will speak at this conference or publish in that periodical is a recipe for disaster when it does not occur and you feel let down or betrayed. Imagining that their logo on a totebag is a sign of imminent release of TLD, or that changes in volume and short interest are an indicator of coming news are just going to lead to disappointment.
None of us have even 10% of the knowledge and data necessary to make an informed decision about when and how to release TLD. Thinking that we are better informed than the people who actually possess that knowledge and data and the experience and expertise to make those decisions, is the very definition of hubris and self-delusion.
I am not saying you rely on blind faith. I am not saying that you do not follow the breadcrumbs. Quite the opposite. You look for what the company is actually doing. NWBO has not been entirely quiet. They have not been sitting on their laurels. They have been actively moving toward approval and commercialization. They did not PR that the certification of the Sawston facility is a necessary step in receiving approval. They did not PR about the changes in guidelines for regulatory approval. But Flaskworks, Sawston, new endpoints, Regulatory changes, patents, and new GBM definitions are all indicators that they are moving ahead and are on track for quick approval once they have everything in place. You just ned to read a bit into the news.
As long as that progress continues and the pieces are put inexorably in place, I am here and so is my money. I am backing up my faith in the company with a great deal more than hollow words and gestures.
You hear, now and then, someone talking about playing with house money. This is not the sign of a winner. It means the person has already lost. Casinos succeed for a couple of reasons. First, they have a built-in advantage in almost every game. But that is not enough to fleece people. Instead, they rely on a large variety of other schemes. No clocks on the walls, confusing layouts, darkness and other things to make it difficult to leave. They rely on people enjoying the experience and being willing to take some losses as the price of entertainment. They use credits on a machine or chips on the table to sever the link between what you are gambling with and the real money it represents.
And they rely on things like the concept of 'house money' to retake their losses. If you are ahead and you can't leave a loser, then you are more likely to take risks or make bad plays. That is what the casino wants. Just like the free drinks, it is a means of getting you to make mistakes, act recklessly. Remember, at the end of the day it is YOUR money once you win it, not the house's. Allowing them to convince you that the source of the money means you can't lose means you have already lost. Especially as your winnings are taxable.
The rest of the market is tanking. Staying still is actually an improvement.
Dude, are you still talking to yourself? Why don't you go play solitaire or something?
It is cool as long as shorts don't get their feeling hurt. Those disappear in < 2 minutes.
You don't need to believe everything everyone says just because they are attacking management and NWBO.
There is nothing wrong with being upset at management. There is nothing wrong with thinking things would have been better if they had done things differently. There is nothing wrong with growing tired of waiting and of hearing nothing.
There is something wrong with allowing that to color your perception of every event or non-event. Sure, there is a great story about Cognate being a cash grab for Linda Powers. It sounds plausible. But you should seriously consider the source of that narrative and what the people saying that are trying to gain. They were not standing up for NWBO shareholders, they were trying to crash the company. For those who had shares before the crash down to $0.20 and lower, the reason they crashed was because of the people spewing the Cognate story and many other false narratives that have since been disproved. The reason people went underwater is because of those people. The reason NWBO has struggled for years trying to stay afloat and is now silent is because of those people.
Recycling their spurious allegations doesn't help your investment and it doesn't present the contrary view. It just rehashes lies and helps the people trying to bankrupt NWBO and fleece their investors. With all of the complete hogwash you see on the Internet we teach our children to pay attention to sources. Look at the professionals and scientists and experts in the field over Facebook. Look at peer-reviewed articles over tweets. Maybe it is too late to teach grownups this lesson.
Really? Holy @#*^$, why hasn't anyone mentioned this before?
Shoot, market closed, too late to sell.
Name one trial whose approval was affected by late release of TLD.
TLD is about your stock porfolio, not about patients. Don't pretend it is about the one when it it only about the other.
pqr: I agree. But it is one of those pipedreams people want to believe in because after the long wait they get a quick payout and move on to other investments. That is fine if that is your goal but I think if it is, then people picked the wrong horse.
RE: ASM_NWBO -
I didn't say they haven't spoken about being bought out, I said they haven't shown any interest in it. When Linda Powers most recently talked about it she showed very little interest. To my mind, everything they have done over the last couple-few years has continued to show an aversion to relinquishing control.
This topic is never ending. People have been talking about buy-outs for years absent any indication it is likely and lots of indications that it isn't. I highly doubt a buyout would be in the best interests of stockholders, other than those interested in a quick buck. I am quite sure it is not in the interests of patients until DC-Vax is too well established to be torpedoed.
Since NWBO has shown no real interest in being bought out, contrary to the expressed wishes of many on this board, it sort of doesn't matter. If Merck wants to save themselves, they will have to figure out a way to convince their Board to do what needs to be done.
Better than talking about tote-bags. I find both discussions tiring.
No need to check them, they are updated weekly. On the second you said how there was some massive dump of warrants that day despite barely any shares trading and only 150K warrants exercised for the entire week as of the FOLLOWING DAY.
It is great that you want people to take you seriously and believe that you have some vague notion about the things you talk about but that is difficult to do when you make up nonsense. And when confronted with that fact and actual evidence you suggest that people who do a job for a living don't know what they are talking about but somehow you do.
Although I admit that if we randomly added 3 million warrants that were not actually exercised then you would have been right. Of course, that is 20X the number of warrants actually exercised that entire week much less that day.
Happy to help learningcurve2020:
No.
Good time to sell that other 75% and buy more TSLA. (https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167238228) TSLA is down what, 20% since that post while NWBO is up about the same? You'll make some real money this time. Guaranteed!
Every single thing you just said is conclusory nonsense, none of which you support with anything but your common sense, devoid of any indication of actual knowledge.
Very few things in life are binary and to say that people don't sit on good news when this company has done exactly that, suggests that you know absolutely nothing about this company or the industry in general. Bad news has to be released in a timely fashion but good news does not. Why? Use your common sense and figure it out. If what you say were actually true they would have been required to disclose it long ago. And common sense says that you do not prepare for approval and ramp up manufacturing for a failed product.